1. Home
  2. ORIC vs UFCS Comparison

ORIC vs UFCS Comparison

Compare ORIC & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • UFCS
  • Stock Information
  • Founded
  • ORIC 2014
  • UFCS 1946
  • Country
  • ORIC United States
  • UFCS United States
  • Employees
  • ORIC N/A
  • UFCS N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • UFCS Property-Casualty Insurers
  • Sector
  • ORIC Health Care
  • UFCS Finance
  • Exchange
  • ORIC Nasdaq
  • UFCS Nasdaq
  • Market Cap
  • ORIC 974.1M
  • UFCS 806.8M
  • IPO Year
  • ORIC 2020
  • UFCS N/A
  • Fundamental
  • Price
  • ORIC $10.92
  • UFCS $30.99
  • Analyst Decision
  • ORIC Strong Buy
  • UFCS Buy
  • Analyst Count
  • ORIC 10
  • UFCS 2
  • Target Price
  • ORIC $17.33
  • UFCS $30.50
  • AVG Volume (30 Days)
  • ORIC 886.3K
  • UFCS 104.0K
  • Earning Date
  • ORIC 11-11-2025
  • UFCS 11-04-2025
  • Dividend Yield
  • ORIC N/A
  • UFCS 2.01%
  • EPS Growth
  • ORIC N/A
  • UFCS 143.32
  • EPS
  • ORIC N/A
  • UFCS 3.51
  • Revenue
  • ORIC N/A
  • UFCS $1,322,727,000.00
  • Revenue This Year
  • ORIC N/A
  • UFCS $12.34
  • Revenue Next Year
  • ORIC N/A
  • UFCS $14.56
  • P/E Ratio
  • ORIC N/A
  • UFCS $9.09
  • Revenue Growth
  • ORIC N/A
  • UFCS 14.18
  • 52 Week Low
  • ORIC $3.90
  • UFCS $19.19
  • 52 Week High
  • ORIC $14.67
  • UFCS $32.22
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 58.68
  • UFCS 53.21
  • Support Level
  • ORIC $10.36
  • UFCS $30.53
  • Resistance Level
  • ORIC $11.16
  • UFCS $32.22
  • Average True Range (ATR)
  • ORIC 0.51
  • UFCS 0.68
  • MACD
  • ORIC 0.06
  • UFCS -0.08
  • Stochastic Oscillator
  • ORIC 75.35
  • UFCS 37.94

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About UFCS United Fire Group Inc.

United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.

Share on Social Networks: